Atypical leiomyomas of the uterus with long-term follow-up after myomectomy with immunohistochemical analysis for p16INK4A, p53, Ki-67, estrogen receptors, and progesterone receptors

International Journal of Gynecological Pathology

Volumn 28, Issue 6, 2009, Pages 529-534

  Sung, Chang Ohk ^a   Ahn, Geunghwan ^a   Song, Sang Yong ^a   Choi, Yoon La ^a   Bae, Duk Soo ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

Atypical leiomyoma; Ki 67; Myomectomy; P16; P53

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; PROTEIN P53; TUMOR MARKER;

ADULT; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; METASTASIS; MYOMECTOMY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; UTERUS MYOMA; BIOSYNTHESIS; LEIOMYOMA; METABOLISM; MIDDLE AGED; PATHOLOGY; UTERUS CANCER;

ADULT; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LEIOMYOMA; MIDDLE AGED; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; UTERINE NEOPLASMS;

EID: 73949136344     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/PGP.0b013e3181a2b8d3     Document Type: Article

References (12)

1. Tavassoli FA, Devilee P. World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Breast and Female Genital Organs. Lyon: IARC Press; 2003.
2. Christopherson WM, Williamson EO, Gray LA. Leiomyosarcoma of the uterus. Cancer 1972;29:1512-1517
3. Hart R, Molnar BG, Magos A. Long term follow up of hysteroscopic myomectomy assessed by survival analysis. Br J Obstet Gynaecol 1999;106:700-705
4. Taylor HB, Norris HJ. Mesenchymal tumors of the uterus. IV. Diagnosis and prognosis of leiomyosarcomas. Arch Pathol 1966;82:40-44
5. Burns B, Curry RH, Bell ME. Morphologic features of prognostic significance in uterine smooth muscle tumors: A review of eighty-four cases. Am J Obstet Gynecol 1979; 135:109-114
6. Downes KA, Hart WR. Bizarre leiomyomas of the uterus: A comprehensive pathologic study of 24 cases with long-term follow-up. Am J Surg Pathol 1997;21:1261-1270
7. Nucci MR. Tumors of the female genital tract: myometrium. In: Fletcher CDM, ed. Diagnostic Histopathology of Tumors. Philadelphia, PA: Elsevier; 2007:684-685
8. Bell SW, Kempson RL, Hendrickson MR. Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol 1994;18:535-558
9. Gannon BR, Manduch M, Childs TJ. Differential immunoreactivity of p16 in leiomyosarcomas and leiomyoma variants. Int J Gynecol Pathol 2008;27:68-73.
10. Chen L, Yang B. Immunohistochemical analysis of p16, p53, and Ki-67 expression in uterine smooth muscle tumors. Int J Gynecol Pathol 2008;27:326-332
11. Mittal K, Demopoulos RI. MIB-1 (Ki-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors. Hum Pathol 2001;32:984-987
12. O'Neill CJ, McBride HA, Connolly LE, et al. Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential. Histopathology 2007;50:851-858